Furthermore, in preclinical colorectal and pancreatic models, macrophage depletion using CSF-1 blocking antibodies, enhances the effectiveness of combined radiotherapy and immune checkpoint inhibitor (anti-PD-L1) treatment suggesting that macrophages act to hinder productive anti-tumor immune functions of radiotherapy (19). Here, CSF1 is linked to neoplasm.